IP Library › Granted Patent US 12,298,210
Granted Patent B2
US 12,298,210 · App. 18/443,049 · Granted May 13, 2025

Preparation of tissue sections using fluorescence-based detection

Inventors: Kyle Schleifer (Somerville, MA); Kristin Briana Bernick (San Jose, CA); Adrienne Mccampbell (San Jose, CA); Nicholas M. Sampas (San Jose, CA); Victor Lim (Pacifica, CA)
Assignee: Agilent Technologies, Inc.
G01N1/30G01N1/06G01N1/286G01N35/00594G06T7/0012G01N2001/068G01N2001/2873G06T2207/10064G06T2207/10152G06T2207/30024
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,298,210
App. No.
18/443,049
Granted
May 13, 2025
Kind
B2
Abstract

The present disclosure is directed to an improved method for distinguishing tissue from an embedding medium, such as paraffin in a formalin-fixed paraffin-embedded sample. The method involves the use of fluorescence of naturally-occurring species in tissue to determine the location of the tissue in the embedded sample. An embedded sample is generally excited by light of a selected wavelength, and the fluorescence emission at an emitted wavelength is used to locate the boundary or location of the tissue in the embedded sample.

Claims (24)

1. A method to distinguish tissue from embedding medium, the method comprising:

irradiating an embedded tissue sample with light having a wavelength of from about 200 nm to about 600 nm, wherein the embedded tissue sample comprises a tissue and an embedding medium, and the tissue is optically indistinguishable from the embedding medium under normal lighting conditions; and

analyzing endogenous fluorescence emission of the embedded tissue sample.

2. The method of claim 1 , wherein the embedding medium is a paraffin.

3. The method of claim 1 , wherein the embedded tissue sample is a formalin-fixed paraffin-embedded (FFPE) tissue block.

4. The method of claim 1 , wherein the endogenous fluorescence emission is detected using an imaging device comprising a camera.

5. The method of claim 4 , wherein a digital image of the endogenous fluorescence emission is used to determine the location of the tissue in the embedded sample.

6. The method of claim 5 , wherein pixel intensity of the digital image is used to determine the location of the tissue in the embedded sample.

7. The method of claim 1 , wherein the method is used to determine a location of a tissue surface.

8. The method of claim 7 , further comprising slicing or trimming a section from the embedded sample after determining the location of the tissue surface.

9. The method of claim 8 , wherein the method comprises staining the section with at least one stain.

10. The method of claim 1 , wherein the light has a wavelength of from about 250 nm to about 450 nm.

11. The method of claim 1 , wherein the endogenous fluorescence emission is generated by autofluorescence of a component of the tissue.

12. The method of claim 11 , wherein the component is elastin or collagen.

13. A method to distinguish tissue from embedding medium in an embedded tissue sample, the method comprising:

providing an embedded tissue sample comprising a tissue and an embedding medium,

irradiating the embedded tissue sample with light having a wavelength of from about 200 nm to about 600 nm, and

analyzing endogenous fluorescence emission of the embedding medium.

14. The method of claim 13 , wherein the embedding medium is a paraffin.

15. The method of claim 13 , wherein the embedded tissue sample is a formalin-fixed paraffin-embedded (FFPE) tissue block.

16. The method of claim 13 , wherein the tissue is optically indistinguishable from the embedding medium under visible lighting conditions.

17. The method of claim 13 , wherein the tissue and the embedding medium are further distinguished by examining endogenous fluorescence emission from the tissue.

18. The method of claim 13 , further comprising determining a location of a tissue surface in the embedded sample.

19. The method of claim 18 , further comprising slicing or trimming a section from the embedded sample after determining the location of the tissue surface.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2024
From: SCHLEIFER, KYLE; BERNICK, KRISTIN BRIANA; MCCAMPBELL, ADRIENNE; SAMPAS, NICHOLAS M.; LIM, VICTOR
To: AGILENT TECHNOLOGIES, INC.
Reel/Frame 066483/0763 →
Continuity (6)
Continuation 17564447 · Dec 29, 2021
Continuation 17129209 · Dec 21, 2020
Continuation 16868715 · May 7, 2020
Continuation 15995755 · Jun 1, 2018
Provisional Application 62537848 · Jul 27, 2017
Related Publication 20240183763A1 · Jun 6, 2024
References Cited (39)
US 10269094B2 · Fuchs · 2019 [cited by applicant]
US 10671832B2 · Hamilton · 2020 [cited by applicant]
US 10684199B2 · Schleifer et al. · 2020 [cited by applicant]
US 10914658B2 · Schleifer et al. · 2021 [cited by applicant]
US 11467071B2 · Mitra · 2022 [cited by examiner]
US 20040026630A1 · Mohun et al. · 2004 [cited by applicant]
US 20060146346A1 · Hoyt · 2006 [cited by applicant]
US 20090091566A1 · Turney et al. · 2009 [cited by applicant]
US 20090220130A1 · Slingerland · 2009 [cited by applicant]
US 20100118133A1 · Walter et al. · 2010 [cited by applicant]
US 20120002043A1 · Nitta · 2012 [cited by applicant]
US 20130023008A1 · Becker et al. · 2013 [cited by applicant]
US 20150050650A1 · Seppo et al. · 2015 [cited by applicant]
US 20150141278A1 · Hollman-Hewgley et al. · 2015 [cited by applicant]
US 20160290926A1 · Notingher et al. · 2016 [cited by applicant]
US 20170191937A1 · Levenson et al. · 2017 [cited by applicant]
US 20180120207A1 · Lim et al. · 2018 [cited by applicant]
US 20190188446A1 · Wu et al. · 2019 [cited by applicant]
US 20190301980A1 · Anderson et al. · 2019 [cited by applicant]
US 20190339203A1 · Miller et al. · 2019 [cited by applicant]
US 20200264077A1 · Schleifer et al. · 2020 [cited by applicant]
US 20210108995A1 · Schleifer et al. · 2021 [cited by applicant]
EP 0209369A2 · 1987 [cited by applicant]
JP 2004515780A · 2004 [cited by applicant]
JP 2009517665A · 2009 [cited by applicant]
JP 2010044069A · 2010 [cited by applicant]
JP 2010230495A · 2010 [cited by applicant]
JP 2015516847A · 2015 [cited by applicant]
JP 2016517985A · 2016 [cited by applicant]
WO 0248692A1 · 2002 [cited by applicant]
WO 2007062444A1 · 2007 [cited by applicant]
WO 2013152395A1 · 2013 [cited by applicant]
WO 2014172530A1 · 2014 [cited by applicant]
WO 2018157074A1 · 2018 [cited by applicant]
Davis, A. S. et al., “Characterizing And Diminishing Autofluorescence In Formalin-Fixed Paraffin-Embedded Human Respiratory Tissue,” Journal of Histochemistry & Cytochemistry, vol. 62, No. 6, 2014, 405-423. [cited by applicant]
EPO, “Extended European Search Report mailed on Oct. 8, 2018,” Application No. 18184642.9, 9 pages. [cited by applicant]
PCT, “Notification of Transmittal of The International Search Report & Written Opinion mailed on Apr. 22, 2022,” Application No. PCT/US2021/065722, Apr. 22, 2022, 11 pages. [cited by applicant]
EPO, et al., “Partial European Search Report (R.164 EPC) mailed on Nov. 28, 2024,” Application No. 21923573.6, 12 pages. [cited by applicant]
Saif, Mari et al., “Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin,” Nature Biomedical Engineering, vol. 4, No. 8, XP037368083, DOI: 10.1038/S4… [cited by applicant]